173
Participants
Start Date
June 30, 2007
Primary Completion Date
May 31, 2008
Study Completion Date
May 31, 2008
IPX056 20 mg
IPX056 Extended Release capsule containing 20 mg baclofen
IPX056 40 mg
IPX056 Extended Release capsule containing 40 mg baclofen
Encapsulated Baclofen 20 mg
Baclofen 20mg tablet was encapsulated for blinding.
Placebo Baclofen Tablet
Placebo capsule encapsulated placebo Baclofen tablet
IPX056 10 mg
IPX056 Extended Release capsule containing 10 mg baclofen
IPX056 30 mg
IPX056 Extended Release capsule containing 30 mg baclofen
IPX056 35 mg
IPX056 Extended Release capsule containing 35 mg baclofen
Placebo IPX056 20 mg
Placebo capsule for IPX056 20 mg
Placebo IPX056 40 mg
Placebo capsule for IPX056 40 mg
West-Tallinn Central Hospital, Tallinn
Winthrop University Hospital, Mineola
Chernihiv Regional Hospital Department of Neurology, Chernihiv
Crozer Chester Medical Center, Upland
Vinnytsya Regional Psychoneurological Hospital, Vinnytsia
Virginia Commonwealth University Medical Center, Richmond
MS Center of Atlanta, Atlanta
Sunrise Clinical Research, Hollywood
Meridien Research, Tampa
Neurology department of Ukraine medical stomatological akademy, Poltava
Elkhardt Clinic, Elkhart
General Clinical Research Center 7A, Ann Arbor
Neurology and Neurosurgery Dpt., Postgraduation training faculty, Dnipropetrovsk State medical Academy, Dnipropetrovsk
Northern Michigan Neurology, Traverse City
Institue of Neruology, Psychiatry and Narcology of AMS of Ukraine, Kharkiv
OSF Saint Francis Medical Center, Peoria
Medex Healthcare Research, Inc., Saint Louis
Odessa Regional Clinical Hospital, Odesa
MidAmerica Neuroscience Institute, Lenexa
OrthoArkansas, P. A., Little Rock
OrthoArkansas, P.A., Little Rock
Integra Clinical Research, San Antonio
Bhupesh Dihenia, Lubbock
Patricia Fodor, Colorado Springs
Northwest NeuroSpecialists, Tucson
Springfield Neurology, Springfield
Neurological Research Center, Bennington
Montreal Neurological Institute and Hospital, Montreal
Foothills Medical Centre, MS Clinic, SSB, Calgary
Vecmilgravis Hospital, Latvian Maritime Medicine Center, Riga
Department of nervous system demyelization diseases of City Clinical Hospital, Kyiv
Lead Sponsor
Impax Laboratories, LLC
INDUSTRY